IMMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Immutep Ltd (IMMP) is not a strong buy at the moment for a beginner investor with a long-term strategy and available capital of $50,000-$100,000. While the stock has potential upside as noted by analysts, the lack of recent positive trading signals, weak technical indicators, and absence of significant news or catalysts make it prudent to hold off on purchasing at this time.
The MACD histogram is negative and expanding (-0.00163), indicating bearish momentum. RSI is neutral at 42.072, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 2.792, with key support at 2.66 and resistance at 2.924. Overall, the technical indicators are mixed, leaning slightly bearish.
Analyst coverage by Citizens with an Outperform rating and a $6 price target, citing strong clinical results and significant upside potential in a bull case.
No recent news or event-driven catalysts. Options data shows a high put-call volume ratio (4.41), indicating bearish sentiment. The stock experienced a pre-market decline of -2.87% and a regular market decline of -1.79%.
No financial data available for analysis. Latest quarter financials could not be assessed due to missing data.
Citizens initiated coverage with an Outperform rating and a $6 price target, highlighting strong clinical results and significant upside potential. However, the bear case downside is estimated at 62%, indicating high risk.
